Novel anti-cancer drugs - Novel anti-cancer drugsNovel anti-cancer drugsNovel anti-cancer drugs

  • Telphone : 123456789
  • Email Address: info@labtechco.com
CONSULTATION
  • Home
  • About Us
    • Leadership
    • R&D center
    • Partnerships
  • Our Product
    • Features
    • Approach
    • Pipeline
  • Our Science
    • Mechanism
    • Publications
  • News & Media
    • New updates
    • Press release
  • Investors Resources
    • General Info
    • Corporate Governance
    • Financial Statements
  • Contacts

Press Release

Press Release

Pet Medical Care

Gongwin’s Compassionate treatment

Gongwin-KY Adopted Compassionate Treatme

Gongwin-KY Completed Case Acceptance for

Gongwin-KY’s endeavors in furry baby can

Zhong Nanshan led Gongwin-KY, the pionee

Gongwin-KY joins hands with three major

2019-11-21 Gongwin-KY Aims at Huge Busin...

2019-11-21 Gongwin-KY’s Liver Cancer New.....Read More

2019-4-12 Gongwin Biopharm Joins Hands...

2019-01-21 Gongwin-KY's Lung Cancer New ...

Gongwin-KY’s skin topical series formula...

Gongwin-KY’s liver cancer new drug PTS10...

"Emerging Market stock" Gongwin-KY was a...

Gongwin-KY’s new drug for adenoid cystic...

Gongwin Biopharm Holdings, Co., Ltd. Cayman (Gongwin-KY; ticker: 6617) founded in 2014 is a Taiwan based clinical stage biopharmaceutical company focused on developing novel anti-cancer drugs.

USEFUL LINKS

  • About Us
  • Pipeline
  • Leadership
  • Contacts
  • Research

OUR SERVICES

  • Scientific
  • Chemistry
  • Gemological
  • Forensic science
  • Immunology

Address

3F., No.80, Sec. 1, Jianguo N. Rd., Zhongshan Dist., Taipei City 104, Taiwan (R.O.C.)

Copyright © 2024 Gongwinbiopharm. All rights reserved.